FDA Approves Johnson & Johnson Pharmaceutical Research & Development, LLC (CA)'s (JOBS) INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
8/3/2009 7:45:20 AM
More...
|
PPD, Inc. (PPDI) Confirms Johnson & Johnson Pharmaceutical Research & Development, LLC (CA)'s (JOBS) Completion of Additional Phase III Studies Providing Expanded Safety and Efficacy Data for Priligy
6/10/2009 7:07:24 AM
More...
|
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain
5/7/2009 12:10:39 PM
More...
|
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
2/6/2009 8:31:36 AM
More...
|
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: Rivaroxaban Reduces Symptomatic VTE & Death Following Knee or Hip Replacement Surgery by More Than 50% Compared to Enoxaparin in Pooled Analysis of the RECORD Clinical Trial Program
12/8/2008 10:48:12 AM
More...
|
FDA Approves Johnson & Johnson (JNJ)'s (JOBS) Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
11/22/2008 2:56:10 PM
More...
|
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: Rivaroxaban Phase II Dose-Ranging Study Demonstrates Encouraging Response Rates in Treatment of Acute Coronary Syndrome Patients
11/10/2008 9:24:33 AM
More...
|
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: New Data Show In Vitro Potency Of Doripenem Against Resistant Bacteria
10/27/2008 3:22:15 PM
More...
|
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Submits New Drug Application to FDA for Carisbamate
10/24/2008 8:36:35 AM
More...
|
Tekmira Pharmaceuticals Corporation Announces Presentation of Data Using SNALP RNAi Delivery Technology
10/22/2008 8:31:08 AM
More...
|
|